Walraven JEW - Search Results

1

Team dynamics and clinician's experience influence decision-making during Upper-GI multidisciplinary team meetings: A multiple case study.

Luijten JCHBM, Westerman MJ, Nieuwenhuijzen GAP, Walraven JEW, Sosef MN, Beerepoot LV, van Hillegersberg R, Muller K, Hoekstra R, Bergman JJGHM, Siersema PD, van Laarhoven HWM, Rosman C, Brom L, Vissers PAJ, Verhoeven RHA. Luijten JCHBM, et al. Among authors: walraven jew. Front Oncol. 2022 Oct 18;12:1003506. doi: 10.3389/fonc.2022.1003506. eCollection 2022. Front Oncol. 2022. PMID: 36330470 Free PMC article.

2

Analysis of 105.000 patients with cancer: have they been discussed in oncologic multidisciplinary team meetings? A nationwide population-based study in the Netherlands.

Walraven JEW, Desar IME, Hoeven van der JJM, Aben KKH, Hillegersberg van R, Rasch CRN, Lemmens VEPP, Verhoeven RHA. Walraven JEW, et al. Eur J Cancer. 2019 Nov;121:85-93. doi: 10.1016/j.ejca.2019.08.007. Epub 2019 Sep 26. Eur J Cancer. 2019. PMID: 31563730 Free article.

3

Preparing tomorrow's medical specialists for participating in oncological multidisciplinary team meetings: perceived barriers, facilitators and training needs.

Walraven JEW, van der Meulen R, van der Hoeven JJM, Lemmens VEPP, Verhoeven RHA, Hesselink G, Desar IME. Walraven JEW, et al. BMC Med Educ. 2022 Jun 27;22(1):502. doi: 10.1186/s12909-022-03570-w. BMC Med Educ. 2022. PMID: 35761247 Free PMC article.

4

Factors influencing the quality and functioning of oncological multidisciplinary team meetings: results of a systematic review.

Walraven JEW, van der Hel OL, van der Hoeven JJM, Lemmens VEPP, Verhoeven RHA, Desar IME. Walraven JEW, et al. BMC Health Serv Res. 2022 Jun 27;22(1):829. doi: 10.1186/s12913-022-08112-0. BMC Health Serv Res. 2022. PMID: 35761282 Free PMC article.

5

The influence of multidisciplinary team meetings on treatment decisions in advanced bladder cancer.

Walraven JEW, Ripping TM, Oddens JR, van Rhijn BWG, Goossens-Laan CA, Hulshof MCCM; BlaZIB Study Group; Kiemeney LA, Witjes JA, Lemmens VEPP, van der Hoeven JJM, Desar IME, Aben KKH, Verhoeven RHA. Walraven JEW, et al. BJU Int. 2023 Feb;131(2):244-252. doi: 10.1111/bju.15856. Epub 2022 Aug 5. BJU Int. 2023. PMID: 35861125 Free PMC article.

6

Facilitators and barriers to conducting an efficient, competent and high-quality oncological multidisciplinary team meeting.

Walraven JEW, Verhoeven RHA, Meulen RV, Hoeven JJMV, Lemmens VEPP, Hesselink G, Desar IME. Walraven JEW, et al. BMJ Open Qual. 2023 Feb;12(1):e002130. doi: 10.1136/bmjoq-2022-002130. BMJ Open Qual. 2023. PMID: 36759037 Free PMC article.

7

Hospital practice variation in the proportion of patients with esophagogastric cancer discussed during an expert multidisciplinary team meeting.

Luijten JCHBM, Vissers PAJ, Geerts J, Lemmens VEP, van Hillegersberg R, Beerepoot L, Walraven JEW, Curvers W, Voncken FEM, van der Sangen M, Verhoeven RHA, Nieuwenhuijzen GAP. Luijten JCHBM, et al. Among authors: walraven jew. Eur J Surg Oncol. 2023 Sep;49(9):106880. doi: 10.1016/j.ejso.2023.03.216. Epub 2023 Mar 15. Eur J Surg Oncol. 2023. PMID: 37055281

8

Pros and cons of streamlining and use of computerised clinical decision support systems to future-proof oncological multidisciplinary team meetings.

Walraven JEW, Verhoeven RHA, van der Hoeven JJM, van der Meulen R, Lemmens VEPP, Hesselink G, Desar IME. Walraven JEW, et al. Front Oncol. 2023 May 18;13:1178165. doi: 10.3389/fonc.2023.1178165. eCollection 2023. Front Oncol. 2023. PMID: 37274246 Free PMC article.

9

Impact of Sepsis on the Oncologic Outcomes of Advanced Epithelial Ovarian Cancer Patients: A Multicenter Observational Study.

Said SA, de Hullu JA, van der Aa MA, Walraven JEW, Bekkers RLM, Slangen BFM, Pickkers P, van Altena AM. Said SA, et al. Among authors: walraven jew. Cancers (Basel). 2023 Sep 20;15(18):4642. doi: 10.3390/cancers15184642. Cancers (Basel). 2023. PMID: 37760610 Free PMC article.

10

Development and Internal Validation of Nomograms for Survival of Advanced Epithelial Ovarian Cancer Based on Established Prognostic Factors and Hematologic Parameters.

Said SA, IntHout J, den Ouden JE, Walraven JEW, van der Aa MA, de Hullu JA, van Altena AM. Said SA, et al. Among authors: walraven jew. J Clin Med. 2024 May 9;13(10):2789. doi: 10.3390/jcm13102789. J Clin Med. 2024. PMID: 38792332 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters